Founders Fund V Management, LLC

Add to watchlist

$1.89 Billion is the total value of Founders Fund V Management, LLC's 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .

All

		Value		Shares		↓ Weighting
AMTI	APPLIED MOLECULAR TRANS INC	$50,409,000	-46.0%	3,611,615	0.0%	2.67%	-91.6%
OSCR	OSCAR HEALTH INCcl a	$45,095,000	-54.9%	5,744,635	0.0%	2.39%	-93.0%
UBX	UNITY BIOTECHNOLOGY INC	$717,000	-68.6%	491,751	0.0%	0.04%	-95.1%

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2022-02-14

Signatures

The EDGAR filing(s) were signed by:

Neil Pai — General Counsel

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
APPLIED MOLECULAR TRANS INC	12	Q3 2023	88.9%
UNITY BIOTECHNOLOGY INC	8	Q3 2022	5.0%
RIGETTI COMPUTING INC	7	Q2 2024	14.7%
UNITY BIOTECHNOLOGY INC	7	Q2 2024	14.7%
OSCAR HEALTH INC	5	Q1 2022	42.2%
CYCLO THERAPEUTICS INC	3	Q2 2024	80.8%
LEAFLY HOLDINGS INC	3	Q3 2022	12.9%
NU HLDGS LTD	2	Q1 2022	94.9%
UBER TECHNOLOGIES INC	2	Q1 2021	64.6%
PORCH GROUP INC	2	Q3 2021	0.7%

View Founders Fund V Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

Founders Fund V Management, LLC Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Applied Molecular Transport Inc.^{Sold out}	February 14, 2024	0	0.0%
ContextLogic Inc.	February 16, 2021	46,739,070	9.8%

View Founders Fund V Management, LLC's complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2024-08-14
13F-HR	2024-05-15
13F-HR	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2023-11-14
13F-HR	2023-08-14
13F-HR	2023-05-15
13F-HR	2023-02-14
13F-HR	2022-11-14
13F-HR	2022-08-15

View Founders Fund V Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Founders Fund V Management, LLC's holdings